Skip to main content
Erschienen in: Familial Cancer 1/2021

21.05.2020 | Original Article

Low accuracy of self-reported family history of melanoma in high-risk patients

verfasst von: Nicholas D. Flint, Michael D. Bishop, Tristan C. Smart, Jennifer L. Strunck, Kenneth M. Boucher, Douglas Grossman, Aaron M. Secrest

Erschienen in: Familial Cancer | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Family history of melanoma is a major melanoma risk factor. However, self-reported family histories for some cancers, including melanoma, are commonly inaccurate. We used a unique database, the Utah Population Database (UPDB), as well as the Utah Cancer Registry to determine the accuracy of self-reported family history of melanoma in a large cohort of high-risk patients. Patient charts were reviewed and compared to records in the UPDB and the UCR to confirm personal and family history of melanoma in 1780 patients enrolled in a total body photography monitoring program. Self-reported family history of melanoma in first-degree relatives had an overall sensitivity of 71%, specificity of 79%, PPV of 31%, and NPV of 95%, with decreased accuracy (PPV) for second-degree relatives. A personal history of melanoma was the only factor significantly associated with accuracy in self-reported family history of melanoma. Patient age, sex, estimated nevus count, and number of prior personal melanomas were not significant predictors. Dermatologists should educate patients on the differences between melanomas, keratinocyte carcinomas, and pre-cancers. Confirming self-reported family history of melanoma may improve risk assessment for patients undergoing screening.
Literatur
6.
Zurück zum Zitat Aitken JF, Youl P, Green A et al (1996) Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 6:313–317CrossRef Aitken JF, Youl P, Green A et al (1996) Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 6:313–317CrossRef
8.
Zurück zum Zitat Weinstock MA, Brodsky GL (1998) Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study. J Clin Epidemiol 51:1299–1303CrossRef Weinstock MA, Brodsky GL (1998) Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study. J Clin Epidemiol 51:1299–1303CrossRef
9.
Zurück zum Zitat Cannon-Albright LA, Thomas A, Goldgar DE et al (1994) Familiality of cancer in Utah. Cancer Res 54:2378–2385PubMed Cannon-Albright LA, Thomas A, Goldgar DE et al (1994) Familiality of cancer in Utah. Cancer Res 54:2378–2385PubMed
10.
Zurück zum Zitat Slattery ML, Kerber RA (1993) A comprehensive evaluation of family history and breast cancer risk. The Utah Popul Database JAMA 270:1563–1568 Slattery ML, Kerber RA (1993) A comprehensive evaluation of family history and breast cancer risk. The Utah Popul Database JAMA 270:1563–1568
18.
Zurück zum Zitat Aitken JF, Green AC, MacLennan R et al (1996) The Queensland Familial Melanoma Project: study design and characteristics of participants. Melanoma Res 6:155–165CrossRef Aitken JF, Green AC, MacLennan R et al (1996) The Queensland Familial Melanoma Project: study design and characteristics of participants. Melanoma Res 6:155–165CrossRef
19.
Zurück zum Zitat Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24:190–198CrossRef Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24:190–198CrossRef
20.
Zurück zum Zitat Novakovic B, Goldstein AM, Tucker MA (1996) Validation of family history of cancer in deceased family members. J Natl Cancer Inst 88:1492–1493CrossRef Novakovic B, Goldstein AM, Tucker MA (1996) Validation of family history of cancer in deceased family members. J Natl Cancer Inst 88:1492–1493CrossRef
21.
Zurück zum Zitat Airewele G, Adatto P, Cunningham J et al (1998) Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 90:543–544CrossRef Airewele G, Adatto P, Cunningham J et al (1998) Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 90:543–544CrossRef
22.
Zurück zum Zitat King TM, Tong L, Pack RJ et al (2002) Accuracy of family history of cancer as reported by men with prostate cancer. Urology 59:546–550CrossRef King TM, Tong L, Pack RJ et al (2002) Accuracy of family history of cancer as reported by men with prostate cancer. Urology 59:546–550CrossRef
26.
Zurück zum Zitat Aitken J, Bain C, Ward M et al (1995) How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 141:863–871CrossRef Aitken J, Bain C, Ward M et al (1995) How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 141:863–871CrossRef
28.
Zurück zum Zitat Mitchell RJ, Brewster D, Campbell H et al (2004) Accuracy of reporting of family history of colorectal cancer. Gut 53:291–295CrossRef Mitchell RJ, Brewster D, Campbell H et al (2004) Accuracy of reporting of family history of colorectal cancer. Gut 53:291–295CrossRef
30.
Zurück zum Zitat Ivanovich J, Babb S, Goodfellow P et al (2002) Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer. Clin Cancer Res 8:1849–1856PubMed Ivanovich J, Babb S, Goodfellow P et al (2002) Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer. Clin Cancer Res 8:1849–1856PubMed
31.
Zurück zum Zitat Kerber RA, Slattery ML (1997) Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146:244–248CrossRef Kerber RA, Slattery ML (1997) Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146:244–248CrossRef
42.
Zurück zum Zitat Qureshi N, Wilson B, Santaguida P et al (2007) Collection and use of cancer family history in primary care. Evid Rep Technol Assess 159:1–84 Qureshi N, Wilson B, Santaguida P et al (2007) Collection and use of cancer family history in primary care. Evid Rep Technol Assess 159:1–84
43.
Zurück zum Zitat Qureshi N, Wilson B, Santaguida P et al (2009) Family history and improving health. Evid Rep Technol Assess 186:1–135 Qureshi N, Wilson B, Santaguida P et al (2009) Family history and improving health. Evid Rep Technol Assess 186:1–135
Metadaten
Titel
Low accuracy of self-reported family history of melanoma in high-risk patients
verfasst von
Nicholas D. Flint
Michael D. Bishop
Tristan C. Smart
Jennifer L. Strunck
Kenneth M. Boucher
Douglas Grossman
Aaron M. Secrest
Publikationsdatum
21.05.2020
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 1/2021
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00187-0

Weitere Artikel der Ausgabe 1/2021

Familial Cancer 1/2021 Zur Ausgabe

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.